Clinical Trials Directory

Trials / Unknown

UnknownNCT04019782

Collagen-PVP vs Hylan G-F 20 in the Treatment of Knee Osteoarthritis

Efficacy Evaluation of Intraarticular Collagen-polyvinyl Pyrrolidone (Fibroquel®) vs Hylan G-F 20 (Synvisc®) in the Treatment of Knee Osteoarthritis. A Double-blind, Controlled, Randomised, Parallel-group Non-inferiority Study

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Coordinación de Investigación en Salud, Mexico · Other Government
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Articular cartilage degradation is the main characteristic of osteoarthritis (OA), involving enzymatic and inflammatory mechanisms that change it into a chronic disease. Since articular cartilage shows limited regenerative ability, several intra-articular drugs have been developed in order to decrease inflammation and provide a better clinical outcome to the patient.

Detailed description

This study aims to compare effectiveness of the treatment with intra-articular administration of collagen-PVP versus hylan GF 20, using the International Knee Documentation Committee (IKDC) score, 6 months after treatment. Hypothesis to test is: If effectiveness of intra-articular collagen-PVP is not lower than hylan GF 20 treatment in knee osteoarthritis subjects, then, statistically significant difference would not exist in IKDC score mean increase among treatment groups, after six months.

Conditions

Interventions

TypeNameDescription
DRUGCollagen-PVPInfiltrations of 1.5 ml collagen-polyvinyl pyrrolidone (collagen-PVP) plus 1 mL of 2% xylocaine without epinephrine, administered by intraarticular injections (three doses, one each 7 days)
DEVICEHylan G-F 20Infiltrations of 2 mL 0.8% Hylan G-F 20 (16 mg) solution, administered by intraarticular injections (three doses, one each 7 days)

Timeline

Start date
2019-08-01
Primary completion
2021-02-28
Completion
2021-08-31
First posted
2019-07-15
Last updated
2019-07-17

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04019782. Inclusion in this directory is not an endorsement.